Status:

COMPLETED

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Lead Sponsor:

Melbourne Health

Conditions:

Bipolar Disorder

Schizoaffective Disorder

Eligibility:

All Genders

15-29 years

Phase:

PHASE4

Brief Summary

Aim: In a population of first episode manic patients with psychotic features, we want to compare the side effect profile, the degree of adherence and the subjective well being, as well as the efficacy...

Detailed Description

This prospective single-centre open trial will compare two groups receiving two different neuroleptics combined with lithium during the first 8 weeks of treatment of a first manic episode. All the pat...

Eligibility Criteria

Inclusion

  • Male and female patients aged 15 to 29.
  • Experiencing a first episode psychosis.
  • Meet DSM-IV criteria for bipolar either manic or mixed episode, or schizoaffective disorder manic episode.
  • Minimum score of 20 on the YMRS
  • Written informed consent to participation.

Exclusion

  • Patients at immediate risk of committing harm to self or others
  • Use of neuroleptics or mood-stabilisers in the two months preceding admission to EPPIC
  • Organic mental disease, including mental retardation
  • History of clinically significant illness (liver or renal insufficiency, significant cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurological or metabolic disturbances).
  • Clinically relevant biochemical or hematological abnormalities.
  • Pregnant or lactating woman
  • History of epilepsy
  • History of severe drug allergy or hypersensitivity
  • Non fluency in English.

Key Trial Info

Start Date :

October 1 2001

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2015

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT00202293

Start Date

October 1 2001

End Date

November 1 2015

Last Update

August 31 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ORYGEN Youth Health

Parkville, Victoria, Australia, 3052